• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃索美拉唑难治性胃食管反流病

[Gastroesophageal reflux disease refractory to esomeprazole].

作者信息

Velasco M J, Ortiz V, Ponce J

机构信息

Servicio de Medicina Digestiva, Hospital Universitari La Fe, Valencia, Spain.

出版信息

Gastroenterol Hepatol. 2005 Feb;28(2):65-7. doi: 10.1157/13070702.

DOI:10.1157/13070702
PMID:15710084
Abstract

Resistance to proton pump inhibitors (PPI) in gastroesophageal reflux disease (GERD), which has been described in patients treated with omeprazole, could explain some exceptional cases of treatment failure and the need for surgery. The objective test of resistance to PPI is obtained with 24-hour intragastric pH-metry performed during treatment. A gastric pH of less than 4 for more than 50% of recording time indicates resistance. We present a patient with non-erosive GERD and treatment failure to omeprazole and proven resistance to esomeprazole which, to our knowledge, has only been reported in patients with Barrett's esophagus.

摘要

胃食管反流病(GERD)患者对质子泵抑制剂(PPI)产生耐药性的情况已在接受奥美拉唑治疗的患者中有所描述,这可以解释一些治疗失败的特殊病例以及手术需求。对PPI耐药性的客观检测是在治疗期间进行24小时胃内pH值测定。记录时间超过50%时胃内pH值小于4表明存在耐药性。我们报告了一名患有非糜烂性GERD的患者,对奥美拉唑治疗无效且已证实对埃索美拉唑耐药,据我们所知,这种情况仅在巴雷特食管患者中报道过。

相似文献

1
[Gastroesophageal reflux disease refractory to esomeprazole].埃索美拉唑难治性胃食管反流病
Gastroenterol Hepatol. 2005 Feb;28(2):65-7. doi: 10.1157/13070702.
2
Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus.埃索美拉唑对巴雷特食管患者反流症状、食管内及胃内pH值的控制疗效。
Dis Esophagus. 2003;16(3):193-8. doi: 10.1046/j.1442-2050.2003.00327.x.
3
Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease.埃索美拉唑40毫克与奥美拉唑40毫克对胃食管反流病症状患者24小时胃内pH值的影响。
Dig Dis Sci. 2002 May;47(5):954-8. doi: 10.1023/a:1015009300955.
4
One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.一周的埃索美拉唑治疗:对疑似胃食管反流病患者的有效验证性试验。
Scand J Gastroenterol. 2003 Apr;38(4):354-9.
5
Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping.给予通用奥美拉唑或埃索美拉唑时的胃内酸度 - 一项包括 CYP2C19 基因分型的随机、两向交叉研究。
Aliment Pharmacol Ther. 2011 Feb;33(4):471-6. doi: 10.1111/j.1365-2036.2010.04544.x. Epub 2010 Dec 22.
6
Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.兰索拉唑与奥美拉唑对胃食管反流病患者胃内酸度及胃食管反流影响的比较
Scand J Gastroenterol. 1998 Dec;33(12):1239-43. doi: 10.1080/00365529850172304.
7
Esomeprazole magnesium (Nexium).埃索美拉唑镁(耐信)。
Rev Gastroenterol Disord. 2001;1(1):32-41.
8
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.埃索美拉唑、兰索拉唑、奥美拉唑、泮托拉唑和雷贝拉唑对胃酸的控制:一项五交叉研究。
Am J Gastroenterol. 2003 Dec;98(12):2616-20. doi: 10.1111/j.1572-0241.2003.08783.x.
9
Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.与奥美拉唑相比,埃索美拉唑能更好地控制胃食管反流病患者的胃酸。
Aliment Pharmacol Ther. 2000 Jul;14(7):861-7. doi: 10.1046/j.1365-2036.2000.00813.x.
10
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.在患有胃食管反流症状的患者中,40毫克埃索美拉唑比30毫克兰索拉唑、20毫克奥美拉唑、40毫克泮托拉唑和20毫克雷贝拉唑能更有效地控制胃内酸度。
Eur J Clin Pharmacol. 2004 Oct;60(8):531-9. doi: 10.1007/s00228-004-0804-6. Epub 2004 Sep 2.